A Bioequivalence Study to Compare Two Formulations of SHR-1314 After Subcutaneous Injection in Healthy Subjects

NCT04527484 · clinicaltrials.gov ↗

PHASE1

Phase

UNKNOWN

Status

130

Enrollment

INDUSTRY

Sponsor class

Conditions

Bioequivalence

Interventions

DRUG: SHR-1314

Sponsor

Jiangsu HengRui Medicine Co., Ltd.